JUNS: Jupiter Neurosciences Inc Company Short-Term Debt

Graphic logo of Jupiter Neurosciences, Inc. (JUNS)

Jupiter Neurosciences Inc (JUNS) is developing a small molecule platform to combat CNS pathologies and Alzheimer's disease. The GURU.Markets website features a chart of the company's short-term borrowings, which illustrates the risks of underfunding and early-stage research failure, with the value stabilizing at 0.00. The lack of a proprietary product and a reliance on equity offerings render the issuer's financial position extremely unstable.

JUNS jupiterneurosciences.com Amount of Current Liabilities (12/04/2024 - 10/30/2026)

Comprehensive metric breakdowns and analytics for Jupiter Neurosciences, Inc. (JUNS)

- current quotes and average value forecast:
Price Chart Jupiter Neurosciences|JUNS - Fair Value Consensus
- market capitalization information:
Market Value Jupiter Neurosciences Inc|JUNS - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Jupiter Neurosciences|JUNS - Total Net Assets|Market Cap to Net Assets Ratio jupiterneurosciences.com|JUNS - Company Total Assets
- debt and liquidity details:
Debt to Equity Jupiter Neurosciences Inc|JUNS - Long-Term Liabilities to Equity|Short-Term Debt to Capital Jupiter Neurosciences Inc|JUNS - Company Total Debt Obligations|Debt to Book Value Jupiter Neurosciences Inc|JUNS - Amount of Long-Term Liabilities|Company Short-Term Debts Jupiter Neurosciences|Quick Liquidity jupiterneurosciences.com
- earnings and multiples data:
JUNS - Final Profit
Fundamental company analysis:Jupiter Neurosciences - JUNS
Mass-produced product of Jupiter Neurosciences, Inc.

This indicator measures the volume of liabilities with maturities of up to twelve months, allowing for an assessment of liquidity and the risk of cash shortages. By analyzing fluctuations in short-term debt, an investor can determine the dependence of Jupiter Neurosciences Inc (JUNS) on borrowed capital when financing costly clinical trials for neurological pathology therapies prior to product commercialization.

Who Jupiter Neurosciences Inc competes with

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|XENE (xenon-pharma.com) - Amount of Current Liabilities|Company Current Liabilities VKTX (Viking Therapeutics, Inc.)|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|DNLI (Denali Corp) - Current Liabilities|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt Volume biohavenpharma.com BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Company Current Liabilities|TRVI: Amount of Current Liabilities|PRAX (Praxis Medicines) - Company Short-Term Debts|Short-Term Debt Anavex Life Sciences Corp AVXL|Company Short-Term Debt CeriBell, Inc. (CBLL)|PRTA (Prothena Corporation plc) - Company Short-Term Loans and Borrowings|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|OMER - Company Short-Term Debt|NGNE (Neurogene Therapeutics) - Company Short-Term Indebtedness|ACIU: Company Short-Term Debts|Short-Term Debt voyagertherapeutics.com (VYGR)|Company Current Liabilities NMRA|Company Short-Term Debts Scilex Holding|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|inhibikase.com (IKT) - Short-Term Debt|SAVA - Company Short-Term Debt|Short-Term Debt Volume Assertio Holdings, Inc. ASRT|COYA: Company Short-Term Debts|Company Current Liabilities Vistagen|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|acumenpharm.com (ABOS) - Short-Term Debt Volume|Company Short-Term Debts CRVO|ATHE - Short-Term Debt|Company Short-Term Debt Clene CLNN|PEPG: Company Short-Term Indebtedness|Relmada Therapeutics - Company Short-Term Debts|annovisbio.com (ANVS) - Company Current Liabilities|GRCE: Company Short-Term Debts|Short-Term Debt Firefly Neuroscience, Inc. (AIFF)|Company Short-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Current Liabilities RVPH (Reviva Pharmaceuticals)|MTVA (metaviatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts NRXS (NeurAxis)|Short-Term Debt Volume Helius Medical Technologies, Inc. (HSDT)|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Company Current Liabilities athira.com|Company Short-Term Debt Addex Therapeutics Ltd|ALZN (Alzamend) - Amount of Current Liabilities|Company Current Liabilities CYCN (Cyclerion Therapeutics)|Company Short-Term Debts protagenic.com (PTIX)|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|CRGT: Company Short-Term Indebtedness|ATXI - Company Short-Term Debt|Short-Term Debt Volume Brainstorm Cell Therapeutics Inc. BCLI|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Company Short-Term Indebtedness CHRO|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Intra-Cellular ITCI|Company Current Liabilities LBPH (Longboard Pharmaceuticals, Inc.)|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|Company Short-Term Loans and Borrowings NRBO|SAGE - Company Short-Term Debt|Short-Term Debt synaptogen.com|Trevena (TRVN) - Company Short-Term Debt|VIGL: Amount of Current Liabilities|Company Current Liabilities WENA|Company Short-Term Debts Cerevel Corp